UChicago Medicine Comprehensive Cancer Center


UChicago Annual Updates from ASH 2019

presented by UChicago Medicine Comprehensive Cancer Center

4 others would like to attend.

Register Now

Notification icon Friday, February 28, 2020 10 AM - 6 PM America/Chicago

Location Icon InterContinental Chicago Magnificent Mile, 505 North Michigan Avenue, Chicago, Illinois 60611

Event info

Our goal is to join community-based providers and academic oncologists to reach our Healthy People 2020 target of 160.0 cancer related deaths per 100,000 individuals or lower. In order to reach this goal, the Annual Updates from ASH 2019: Practice Changing Abstracts addresses early treatment options and medical advances that can be implemented in an effort to reduce cancer related deaths. It will provide physicians and other healthcare professionals with information that will improve their competence and ultimately improve patient outcomes by bridging the gap between the level of care provided in the community and the care provided at an academic medical center. By providing them with important developments from the most recent ASH conference, we want to educate and empower community-based oncologists on best practices for treating hematologic cancers and also inform them of the indicators of when a patient needs to be referred for tertiary level care


This activity is designed for physicians and other healthcare professionals interested in the treatment of hematologic cancers.


Upon completion of this program, participants should be able to: ·

  • Discuss how the biology of leukemia has influenced treatment approaches;
  • Describe next generation improvements in CAR T-cell therapies that can improve patient outcomes;
  • Identify methods for integrating therapeutic advances into practice to improve current myeloma patient care;
  • List current best practice in first and second line therapies for lymphoid malignancies;Name new technologies for the treatment of hemophilia;
  • Analyze how new scientific insights are informing diagnosis and treatment of myelodysplastic/myeloproliferative neoplasms.


The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information, or to register, plesae visit the meeting website.

Course Syllabus

Click HERE to view the syllabus

4 others would like to attend.

Register Now

Login to view comments. Click here to Login